Latest Breaking News On - Radoslaw kaczmarek - Page 1 : vimarsana.com

 E-Mail A group of scientists have just made a key discovery that could prevent and eradicate immune responses that lead to treatment failure in about one-third of people with severe hemophilia A. Hemophilia is the most common severe inherited bleeding disorder in men. The disease affects 1 in 10,000 males worldwide and results from deficiency of blood clotting factor VIII (FVIII). Both children and adults with hemophilia A (80 percent of all hemophilia) receive treatment that involves infusing FVIII protein into the bloodstream. However, about 30 percent of them develop an immune response in the form of antibodies to FVIII (inhibitors), rendering treatment ineffective and increasing risk of mortality.

University schoolUnited statesUniversity of pennsylvaniaShannonl meeksMostafaa shaheenCindy leissingerBhavya doshiRadoslaw kaczmarekValderr arrudaJohns butterfieldJyoti ranaGiancarlo castamanHermanb wells centerIu school of medicinePerelman school of medicinePediatric research